| Michelle Belle Eason-delhougne, MD | |
|
2352 Meadows Blvd, Ste 300, Castle Rock, CO 80109-8406 | |
| (720) 455-3750 | |
| (720) 455-3751 |
| Full Name | Michelle Belle Eason-delhougne |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 27 Years |
| Location | 2352 Meadows Blvd, Castle Rock, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407969595 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | CO 39425 (Colorado) | Primary |
| 208000000X | Pediatrics | CO 39425 (Colorado) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| First Class Urgent Care Pc | 5092068577 | 10 |
| Obgyn Affiliates | 6608765060 | 42 |
News Archive
Damaging DNA builds up in the eyes of patients with geographic atrophy, an untreatable, poorly understood form of age-related macular degeneration that causes blindness, new research from the University of Virginia School of Medicine reveals.
Chronic low back pain can limit everyday activities, including sex. New research presented today at the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS), found that 70 percent of patients consider sexual activity "relevant" to their life quality, and patients who receive surgical treatment for spinal spondylolisthesis (DS) and spinal stenosis (SS)-common degenerative conditions most often occurring in older adults-were twice as likely to report no pain during sex.
GHX today announced it has partnered with PTC (Nasdaq: PTC) to offer a solution to help medical-surgical manufacturers meet both commercial and regulatory compliance needs, including the submission requirements of the U.S. Food and Drug Administration's (FDA) new Unique Device Identification (UDI) rule.
bioMerieux has signed an agreement with GlaxoSmithKline to develop a predictive test to help clinicians select the most appropriate treatment for different segments of breast cancer patients.
Researchers from Massachusetts Eye and Ear/Harvard Medical School have identified inflammatory factors that cause optic neuropathy in the back of the eye following implantation of a keratoprosthesis (KPro) — similar to what glaucoma patients experience, without the rise of pressure in the eye — and have shown that blocking one of those factors, tumor necrosis factor alpha (TNFa), successfully halts the development of optic nerve damage in a mouse model.
› Verified 4 days ago
| Entity Name | Obgyn Affiliates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134185721 PECOS PAC ID: 6608765060 Enrollment ID: O20040312001142 |
News Archive
Damaging DNA builds up in the eyes of patients with geographic atrophy, an untreatable, poorly understood form of age-related macular degeneration that causes blindness, new research from the University of Virginia School of Medicine reveals.
Chronic low back pain can limit everyday activities, including sex. New research presented today at the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS), found that 70 percent of patients consider sexual activity "relevant" to their life quality, and patients who receive surgical treatment for spinal spondylolisthesis (DS) and spinal stenosis (SS)-common degenerative conditions most often occurring in older adults-were twice as likely to report no pain during sex.
GHX today announced it has partnered with PTC (Nasdaq: PTC) to offer a solution to help medical-surgical manufacturers meet both commercial and regulatory compliance needs, including the submission requirements of the U.S. Food and Drug Administration's (FDA) new Unique Device Identification (UDI) rule.
bioMerieux has signed an agreement with GlaxoSmithKline to develop a predictive test to help clinicians select the most appropriate treatment for different segments of breast cancer patients.
Researchers from Massachusetts Eye and Ear/Harvard Medical School have identified inflammatory factors that cause optic neuropathy in the back of the eye following implantation of a keratoprosthesis (KPro) — similar to what glaucoma patients experience, without the rise of pressure in the eye — and have shown that blocking one of those factors, tumor necrosis factor alpha (TNFa), successfully halts the development of optic nerve damage in a mouse model.
› Verified 4 days ago
| Entity Name | First Class Urgent Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588148241 PECOS PAC ID: 5092068577 Enrollment ID: O20181031000048 |
News Archive
Damaging DNA builds up in the eyes of patients with geographic atrophy, an untreatable, poorly understood form of age-related macular degeneration that causes blindness, new research from the University of Virginia School of Medicine reveals.
Chronic low back pain can limit everyday activities, including sex. New research presented today at the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS), found that 70 percent of patients consider sexual activity "relevant" to their life quality, and patients who receive surgical treatment for spinal spondylolisthesis (DS) and spinal stenosis (SS)-common degenerative conditions most often occurring in older adults-were twice as likely to report no pain during sex.
GHX today announced it has partnered with PTC (Nasdaq: PTC) to offer a solution to help medical-surgical manufacturers meet both commercial and regulatory compliance needs, including the submission requirements of the U.S. Food and Drug Administration's (FDA) new Unique Device Identification (UDI) rule.
bioMerieux has signed an agreement with GlaxoSmithKline to develop a predictive test to help clinicians select the most appropriate treatment for different segments of breast cancer patients.
Researchers from Massachusetts Eye and Ear/Harvard Medical School have identified inflammatory factors that cause optic neuropathy in the back of the eye following implantation of a keratoprosthesis (KPro) — similar to what glaucoma patients experience, without the rise of pressure in the eye — and have shown that blocking one of those factors, tumor necrosis factor alpha (TNFa), successfully halts the development of optic nerve damage in a mouse model.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michelle Belle Eason-delhougne, MD 2352 Meadows Blvd, Ste 300, Castle Rock, CO 80109-8406 Ph: (720) 455-3750 | Michelle Belle Eason-delhougne, MD 2352 Meadows Blvd, Ste 300, Castle Rock, CO 80109-8406 Ph: (720) 455-3750 |
News Archive
Damaging DNA builds up in the eyes of patients with geographic atrophy, an untreatable, poorly understood form of age-related macular degeneration that causes blindness, new research from the University of Virginia School of Medicine reveals.
Chronic low back pain can limit everyday activities, including sex. New research presented today at the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS), found that 70 percent of patients consider sexual activity "relevant" to their life quality, and patients who receive surgical treatment for spinal spondylolisthesis (DS) and spinal stenosis (SS)-common degenerative conditions most often occurring in older adults-were twice as likely to report no pain during sex.
GHX today announced it has partnered with PTC (Nasdaq: PTC) to offer a solution to help medical-surgical manufacturers meet both commercial and regulatory compliance needs, including the submission requirements of the U.S. Food and Drug Administration's (FDA) new Unique Device Identification (UDI) rule.
bioMerieux has signed an agreement with GlaxoSmithKline to develop a predictive test to help clinicians select the most appropriate treatment for different segments of breast cancer patients.
Researchers from Massachusetts Eye and Ear/Harvard Medical School have identified inflammatory factors that cause optic neuropathy in the back of the eye following implantation of a keratoprosthesis (KPro) — similar to what glaucoma patients experience, without the rise of pressure in the eye — and have shown that blocking one of those factors, tumor necrosis factor alpha (TNFa), successfully halts the development of optic nerve damage in a mouse model.
› Verified 4 days ago
Dr. Umberto N Orazi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1189 S Perry St, Suite 230, Castle Rock, CO 80104 Phone: 303-688-5025 Fax: 303-688-5029 | |
Christopher Haydek, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 3911 Ambrosia St Ste 201, Castle Rock, CO 80109 Phone: 303-788-8888 Fax: 844-347-5158 | |
Olga Dobranowski, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6301 Ellingwood Point Pl, Castle Rock, CO 80108 Phone: 630-915-4086 | |
Dr. Anthony Joseph Cedrone, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2352 Meadows Blvd Ste 115, Castle Rock, CO 80109 Phone: 303-744-1065 Fax: 303-733-1699 | |
Christine B Walden, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4318 Trail Boss Dr, Suite 100, Castle Rock, CO 80104 Phone: 303-338-4545 | |
James Coates, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 5057 Castle Pines Dr S, Castle Rock, CO 80108 Phone: 720-381-0510 |